Toronto Dominion Bank
PRAX icon

Toronto Dominion Bank’s Praxis Precision Medicines PRAX Stock Holding History

Toronto Dominion Bank’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,000
Closed -$547K – 2062
2025
Q2 		$547K Buy
+13,000
New +$495K ﹤0.01% 1172

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Toronto Dominion Bank's PRAX Position: Q1 2026 in Review

Toronto Dominion Bank opened a new position in Praxis Precision Medicines (PRAX) in Q1 2026: 289 shares worth $93.1K. The stake represents ﹤0.01% of the portfolio and ranks #1691 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in PRAX as recently as Q2 2025.

Toronto Dominion Bank first reported a position in PRAX in Q2 2023 and has held it in 4 quarters since. The position peaked at $130K in Q2 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Toronto Dominion Bank held 289 shares of Praxis Precision Medicines worth $93.1K as of Q1 2026.
  • Praxis Precision Medicines was a new Toronto Dominion Bank position in Q1 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1691 holding.
  • Toronto Dominion Bank first reported a position in Praxis Precision Medicines in Q2 2023 and has held it in 4 quarters since.
  • Toronto Dominion Bank's Praxis Precision Medicines position peaked at $130K in Q2 2025.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.